What is the price target for IVVD stock?
10 analysts have analysed IVVD and the average price target is 8.16 USD. This implies a price increase of 458.9% is expected in the next year compared to the current price of 1.46.
NASDAQ:IVVD • US00534A1025
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INVIVYD INC (IVVD).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-26 | BTIG | Reiterate | Buy -> Buy |
| 2025-12-23 | BTIG | Reiterate | Buy -> Buy |
| 2025-12-22 | BTIG | Initiate | Buy |
| 2025-11-25 | D. Boral Capital | Downgrade | Buy -> Hold |
| 2025-11-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-31 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-06 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-10-06 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-08-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-25 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-19 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-15 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-26 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-16 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-20 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-05 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-24 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-03 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-01-27 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-01-10 | D. Boral Capital | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 25.384M | 53.426M 110.47% | 86.318M 61.57% | 122.07M 41.42% | 221.58M 81.52% | 346.12M 56.21% | 502.01M 45.04% | 624.69M 24.44% | 737.32M 18.03% | 847.79M 14.98% | ||
| EBITDA YoY % growth | -207.303M 10.11% | -175.41M 15.38% | -54.805M 68.76% | -95.472M -74.20% | -87.312M 8.55% | 84.252M 196.50% | 225.52M 167.67% | 401.88M 78.20% | 449.41M 11.83% | N/A | N/A | |
| EBIT YoY % growth | -207.783M 9.92% | -176.876M 14.87% | -55.56M 68.59% | -31.832M 42.71% | -35.472M -11.44% | 42.595M 220.08% | 65.551M 53.89% | 169.54M 158.64% | 255.83M 50.90% | 302.88M 18.39% | 379.72M 25.37% | |
| Operating Margin | N/A | -696.80% | -103.99% | -36.88% | -29.06% | 19.22% | 18.94% | 33.77% | 40.95% | 41.08% | 44.79% | |
| EPS YoY % growth | -1.81 12.56% | -1.49 17.68% | -0.36 75.84% | -0.16 54.67% | -0.18 -12.50% | 0.06 131.94% | 0.02 -73.91% | 0.30 1,866.67% | 0.59 96.61% | 0.92 55.17% | 1.09 18.33% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.07 46.57% | -0.08 32.00% | -0.10 -58.66% | -0.10 -155.00% | -0.08 -9.10% | -0.07 12.50% | -0.07 25.00% | -0.05 50.00% |
| Revenue Q2Q % growth | 18.411M 62.87% | 20.451M 73.52% | 20.298M 54.60% | 21.216M 23.30% | 24.786M 34.63% | 27.132M 32.67% | 30.294M 49.25% | 34.884M 64.42% |
| EBITDA Q2Q % growth | -21.318M -28.30% | -24.276M -66.24% | -25.806M -147.73% | -24.174M -104.86% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -21.624M -27.79% | -24.582M -63.23% | -26.112M -136.89% | -24.48M -94.98% | N/A | N/A | N/A | N/A |
All data in USD
10 analysts have analysed IVVD and the average price target is 8.16 USD. This implies a price increase of 458.9% is expected in the next year compared to the current price of 1.46.
INVIVYD INC (IVVD) will report earnings on 2026-05-07.
The consensus EPS estimate for the next earnings of INVIVYD INC (IVVD) is -0.07 USD and the consensus revenue estimate is 18.41M USD.
The number of analysts covering INVIVYD INC (IVVD) is 10.